Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:41 pm Purchase | 2022-12-31 | 13G | WHOLE EARTH BRANDS, INC. CLASS FREE | Armistice Capital, LLC | 2,475,802 5.900% | 2,475,802![]() (New Position) | Filing History |
| 2023-02-14 12:41 pm Sale | 2022-12-31 | 13G | PHAXIAM THERAPEUTICS S.A. AMER PHXM | Armistice Capital, LLC | 162,912 4.990% | -110,813![]() (-40.48%) | Filing History |
| 2023-02-14 12:39 pm Purchase | 2022-12-31 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Armistice Capital, LLC | 2,078,000 9.990% | 1,022,000![]() (+96.78%) | Filing History |
| 2023-02-14 12:39 pm Sale | 2022-12-31 | 13G | ENERGY FOCUS, INC PAR EFOI | Armistice Capital, LLC | 71,856 4.990% | -17,818![]() (-19.87%) | Filing History |
| 2023-02-14 12:35 pm Purchase | 2022-12-31 | 13G | DYNATRONICS CORP DYNT | Armistice Capital, LLC | 997,004 4.990% | 671,004![]() (+205.83%) | Filing History |
| 2023-02-14 12:32 pm Purchase | 2022-12-31 | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Armistice Capital, LLC | 5,172,000 7.650% | 1,741,846![]() (+50.78%) | Filing History |
| 2023-02-14 12:30 pm Unchanged | 2022-12-31 | 13G | CYCLO THERAPEUTICS INC CYTH | Armistice Capital, LLC | 1,030,000 10.830% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:29 pm Purchase | 2022-12-31 | 13G | CLARUS THERAPEUTICS HLDGS INC CRXTQ | Armistice Capital, LLC | 2,732,169 4.990% | 279,793![]() (+11.41%) | Filing History |
| 2023-02-14 12:28 pm Purchase | 2022-12-31 | 13G | CORETEC GROUP INC CRTG | Armistice Capital, LLC | 13,432,528 4.990% | 13,432,528![]() (New Position) | Filing History |
| 2023-02-14 12:27 pm Sale | 2022-12-31 | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Armistice Capital, LLC | 0 0.000% | -9,572,000![]() (Position Closed) | Filing History |
| 2023-02-14 12:24 pm Purchase | 2022-12-31 | 13G | CONNEXA SPORTS TECHNOLOGIES IN CNXA | Armistice Capital, LLC | 32,310 9.990% | 32,310![]() (New Position) | Filing History |
| 2023-02-14 12:23 pm Purchase | 2022-12-31 | 13G | CNS PHARMACEUTICALS INC N CNSP | Armistice Capital, LLC | 6 9.990% | 6![]() (New Position) | Filing History |
| 2023-02-14 12:23 pm Purchase | 2022-12-31 | 13G | CHECKPOINT THERAPEUTICS INC CO CKPT | Armistice Capital, LLC | 987,211 9.990% | 987,211![]() (New Position) | Filing History |
| 2023-02-14 12:22 pm Purchase | 2022-12-31 | 13G | CONTRAFECT CORP COM CFRX | Armistice Capital, LLC | 60,358 9.990% | 60,358![]() (New Position) | Filing History |
| 2023-02-14 12:20 pm Unchanged | 2022-12-31 | 13G | CONFORMIS INC CFMS | Armistice Capital, LLC | 480,000 6.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:19 pm Purchase | 2022-12-31 | 13G | CODIAK BIOSCIENCES INC CDAKQ | Armistice Capital, LLC | 2,666,666 6.750% | 2,666,666![]() (New Position) | Filing History |
| 2023-02-14 12:18 pm Purchase | 2022-12-31 | 13G | BAUDAX BIO INC PAR $0.01 BXRXQ | Armistice Capital, LLC | 1,165,709 4.990% | 1,159,374![]() (+18301.09%) | Filing History |
| 2023-02-14 12:16 pm Sale | 2022-12-31 | 13G | BIT DIGITAL, INC. BTBT | Armistice Capital, LLC | 3,161,889 3.690% | -1,053,963![]() (-25.00%) | Filing History |
| 2023-02-14 12:15 pm Purchase | 2022-12-31 | 13G | BRUUSH ORAL CARE INC BRSH | Armistice Capital, LLC | 44,917 9.990% | 44,917![]() (New Position) | Filing History |
| 2023-02-14 12:06 pm Purchase | 2022-12-31 | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Armistice Capital, LLC | 955,995 9.990% | 23,943![]() (+2.57%) | Filing History |

